Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Eli Lilly and Company
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has type 2 diabetes treated with either: \*A stable regimen of metformin for a minimum of 3 months, and/or \*Diet modification and exercise for a minimum of 3 months.
Has HbA1c of 7.1% to 11.0%, inclusive.
Has a body mass index (BMI) of 25 kg/m2 to 45 kg/m2, inclusive.
You may not be if
Received any investigational drug within 3 months prior to screening.
Is currently treated with any of the following excluded medications: \*Thiazolidinediones within 3 months of screening; \* Sulfonylureas within 3 months of screening; \* Insulin within 1 year of screening.
Participated previously in an exenatide clinical study.
Clareo Health | Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
